2018
DOI: 10.3389/fphar.2018.00531
|View full text |Cite
|
Sign up to set email alerts
|

Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade

Abstract: Because of the essential role of signal transducer and activator of transcription 3 (STAT3) in proliferation, anti-apoptosis, and chemoresistance of multiple myeloma (MM), we investigated whether icariin, a prenylated flavonol glycoside, inhibits both constitutive and inducible STAT3 activation in human myeloma cell lines. We noted that icariin could block constitutive STAT3 phosphorylation as well as its nuclear translocation and DNA binding ability in U266 cells. Icariin also suppressed IL-6-induced STAT3 ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
63
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

6
2

Authors

Journals

citations
Cited by 71 publications
(63 citation statements)
references
References 52 publications
0
63
0
Order By: Relevance
“…Recently, the anti-tumor activity of ICA was reviewed [12]. It exhibited appreciable cytotoxicity against several types of cancer cells [13,14]. ICA demonstrates apoptotic effect via the intrinsic pathway [15].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently, the anti-tumor activity of ICA was reviewed [12]. It exhibited appreciable cytotoxicity against several types of cancer cells [13,14]. ICA demonstrates apoptotic effect via the intrinsic pathway [15].…”
Section: Introductionmentioning
confidence: 99%
“…ICA has poor bioavailability which can be attributed to its chemical structure. It is a diglycoside and not readily absorbed [14,21]. Its oral half-life is 3.15 h and its serum level after intravenous administration suffers rapid decline with a half-life of 0.56 h [22,23].…”
Section: Introductionmentioning
confidence: 99%
“…EMSA was performed to analyze the interaction of STAT3-DNA as described previously [47,48]. Briefly, cells were subjected to ACHP treatment (10 µM for 4 h) and the nuclear extract was prepared.…”
Section: Electrophoretic Mobility Shift Assay (Emsa)mentioning
confidence: 99%
“…The protein-oligonucleotide complex was subjected to PAGE and blotted to a nylon membrane, followed by cross-linkage with UV. Lastly, the mobility of proteins was examined using a LightShift ® Chemiluminescent EMSA kit (Waltham, MA, USA) [47].…”
Section: Electrophoretic Mobility Shift Assay (Emsa)mentioning
confidence: 99%
“…We input each data point to calculate a combination index (CI) and to select a moderate combination rate. This was then used to evaluate synergy and antagonism: CI < 1, CI = 1, and CI >1, respectively [18,43,47].…”
Section: Combination Therapy With Ddz and Bortezomibmentioning
confidence: 99%